Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211995 Therapy for drug resistance bacteria
11/13/2003US20030211994 Composition and method for modulating vasculogenesis or angiogenesis
11/13/2003US20030211993 Control cell proliferation, cell differentiation; culture product
11/13/2003US20030211992 Method for treating cartilage disorders
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211988 Enhancing lymph channel development and treatment of lymphatic obstructive disease
11/13/2003US20030211987 Dna libraries; genetic engineered nucleic acids
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211983 Pharmaceutical preparations comprising cyclosporin for oral administration
11/13/2003US20030211982 Beta turn peptidomimetic cyclic compounds
11/13/2003US20030211981 Antidiabetic agents; vision disorders
11/13/2003US20030211980 Antibody; controlling cell activation
11/13/2003US20030211979 FAP-activated anti-tumor compounds
11/13/2003US20030211977 Muscle relaxants; anticoagulants; cardiovascular disorders
11/13/2003US20030211976 Antidiabetic agents
11/13/2003US20030211975 Method and apparatus for vascular neuromuscular blockade
11/13/2003US20030211974 Sustained release of drug using biocompatible polymer
11/13/2003US20030211972 Systemic administration of a therapeutic preparation
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211967 Method for selectively inhibiting ghrelin action
11/13/2003US20030211966 Novel pharmacotherapeutic process and composition for central nervous system disorders
11/13/2003US20030211965 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
11/13/2003US20030211964 Method of inhibiting pathogenicity of infectious agents
11/13/2003US20030211611 Antisense modulation of estrogen receptor alpha expression
11/13/2003US20030211610 Comprises oligonucleotide for suppressing activity of a disintegrin and metalloproteinase (ADAM) enzyme and treating osteoarthritis, inflammation and blood disorders; gene expression inhibition
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211598 Administering antitumor agents to tissues having an epithelial membrane; drug delivery; gene therapy
11/13/2003US20030211597 Genetically engineered hepatitis C viral (HVC) particle for use in prevention, diagnosis and prognostication of viral infections; immunoassays; genetic vaccines diagnosis
11/13/2003US20030211592 Methods of terminal sterilization of biological products
11/13/2003US20030211589 Cyclic peptides which function as inhibitors of kinase activity for treating cancer, arteriosclerosis, psoriasis, inflammation and septic shock
11/13/2003US20030211583 Egs molecules that specifically downregulae bcl-xl experession
11/13/2003US20030211580 Comprises synthetic follicle stimulating hormone for increasing fertility, egg production and spermatogenesis
11/13/2003US20030211578 Comprises nucleotide sequences coding membrane protein for diagnosing and treating autoimmune diseases; drug screening
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211561 Human oxalyl-CoA decarboxylase
11/13/2003US20030211559 Comprises composition for identifying therapeutic agents that inhibit proteolytic processing of amyloid precursor protein; treating nervous system disorders
11/13/2003US20030211549 Functional proteins and therapeutic and diagnostic methods for use thereof
11/13/2003US20030211545 Using enzyme inhibitors to treat neuropsychological disorders such as schizophrenia and bipolar disorder; neuroleptic agents
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211537 Comprises nucleotide sequences coding membrane protein (MORD1) for screening and/or detection of opioid ligands; drug screening and design; analgesics; pain management
11/13/2003US20030211533 Method for testing a therapeutic or preventive agent for hyperlipidemia
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211525 Comprise nucleotide sequences coding cell cycle protein for use in diagnosis, prognosis and treatment of cancer and autoimmune diseases
11/13/2003US20030211521 Breast cancer antigen
11/13/2003US20030211519 Identifying angiogenesis inhibitor for treating cell proliferative disorders; antitumor agents
11/13/2003US20030211517 Comprises nucleotide sequences coding immunoglobulin protein for diagnosing and treating tumorous and nervous system disorders
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211514 Comprises nucleotide sequences coding polypeptide for use in diagnosis and treatment of neoplastic and neurodegenerative diseases
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211510 For stimulating and/or expanding T cells specific for lung tumors diagnosis, prevention and/or treatment of diseases, particularly lung cancer
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211485 Novel proteins and nucleic acids encoding same
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003US20030211476 Modulating protein expression/translation/concentration in cells; vaccine/drug delivery
11/13/2003US20030211472 125 human secreted proteins
11/13/2003US20030211465 Viricidal compound for prevention and treatment of human lymphadenopathy associated viral infection; immunotherapy
11/13/2003US20030211463 Monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy
11/13/2003US20030211172 Composition and method for substantially reducing the deleterious effects of alcohol on the body
11/13/2003US20030211167 Aqueous solution of amylopectin starch and drugs; injectable
11/13/2003US20030211153 Somatotropin in biocompatible polymer matrix; aqueous solution administering by injection
11/13/2003US20030211143 Emulsion and micellar formulations for the delivery of biologically active substances to cells
11/13/2003US20030211141 Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies
11/13/2003US20030211136 Mixture of water soluble polymer, taste masking compound and drug
11/13/2003US20030211133 Mixture of methylcobalamin and vitamin b
11/13/2003US20030211121 Therapeutic treatments for neuropsychiatric disorders
11/13/2003US20030211117 Synthetic antigen for the detection of aids-related disease
11/13/2003US20030211113 Administering immunosuppressant
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211104 Methods of using cytokine antagonists to treat HIV infection and AIDS
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211098 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
11/13/2003US20030211097 Epidermal growth factor; antitumor, anticancer agents
11/13/2003US20030211095 Peptide for regulation of urokinase plasminogen activator and method of optimizing therapeutic efficacy
11/13/2003US20030211094 High molecular weight derivatives of vitamin k-dependent polypeptides
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211080 Congestive heart failure; monitoring gene expression; supplying adeno-associated viral vector
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030211078 Therapy for restenosis; antiischemic agents; antitumor agents; anticancer agents; complexing
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030211076 Compositions and methods for treatment of proliferative disorders
11/13/2003US20030211075 Mixture of sensitizer and tissue factor
11/13/2003US20030211047 High speed absorption; mixture of aqueous polar solvent, propellant, active material and flavor
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003US20030211039 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
11/13/2003CA2494542A1 Preventing secondary lymphedema with vegf-d dna
11/13/2003CA2493957A1 Method of enhancing biological activity of plant extracts
11/13/2003CA2489009A1 Connective tissue stimulating peptides
11/13/2003CA2487274A1 Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
11/13/2003CA2485216A1 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
1 ... 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 ... 3163